Recent Securities Litigations

Annovis Bio, Inc. (NYSE: ANVS)

21 Days left to seek lead plaintiff status.

Company Name:Annovis Bio, Inc.
Stock Symbol:NYSE: ANVS
Class Period Start:05/21/2021
Class Period End (inclusive):07/28/2021
Filing Deadline:10/18/2021

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that Annovis’s ANVS401 did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Annovis Bio, Inc. (NYSE: ANVS) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.